Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation

Transplantation

Volumn 57, Issue 1, 1994, Pages 73-81

  Florijn, Klaas W ^a   Chang, Peter C ^a   Van Der Woude, Fokko J ^a   Van Bockel, J Hajo ^a   Van Saase, Jan L C M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRECTOMY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0028044816     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199401000-00014     Document Type: Article

References (47)

1. Gabow PA. Autosomal dominant polycystic kidney disease-more than a renal disease. Am J Kidney Dis 1990; 16: 403.
2. Leier CV, Baker PB, Kilman JW, Wooley CF. Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med 1984; 100: 683.
3. Timio M, Monarca C, Pede S, Gentili S, Verdura C, Lolli S. The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10-year follow-up in a five-generation kindred. Clin Nephrol 1992; 37: 245.
4. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA. Echocardiographie findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 907.
5. Levey AS, Pauker SG, Kassirer JP. Occult intracranial aneurysms in polycystic kidney disease. N Engl J Med 1983; 308: 986.
6. Wakabayashi T, Fujita S, Ohbora Y, Suyama T, Tamaki N, Matsumoto S. Polycystic kidney disease and intracranial aneurysms. J Neurosurg 1983; 58: 488.
7. Ryu S. Intracranial hemorrhage in patients with polycystic kidney disease. Stroke 1990; 21: 291.
8. Nishioka H, Tomer JC, Graf CJ, Kassell NF, Sahs AL, Goettler LC. Cooperative study of intracranial aneurysms and subarachnoid hemorrhage: a long-term prognostic study. Arch Neurol 1984; 41: 1142.
9. Cole BR, Conley SB, Stapleton FB. Polycystic kidney disease in the first year of life. J Pediatr 1987; 111: 693.
10. Sedman A, Bell P, Manco-Johnson M, et al. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int 1987; 31: 1000.
11. Hansson L, Karlander L, Lundgren W, Peterson L. Hypertension in polycystic kidney disease. Scand J Urol Nephrol 1974; 8: 203.
12. Florijn KW, van Saase JLCM, Breuning MH, Chang PC. Auto somal-dominant polycystic kidney disease and hypertension: a review. Contrib Nephrol 1992; 97: 71.
13. Tzardis PJ, Gruessner RWG, Matas AJ, et al. Renal transplanttation in patients with polycystic kidney disease: a single-center experience. Clin Transplant 1989; 3: 325.
14. Fitzpatrick PM, Torres VE, Charboneau JW, Offord KP, Holley KE, Zincke H. Long-term outcome of renal transplantation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1990; 15: 535.
15. Gàbel H, Brynger H. Renal transplantation in patients with polycystic kidney disease in Gothenburg. Scand J Urol Nephrol 1980; (suppl 54): 76.
16. Singh S, Hariharan S. Renal replacement therapy in autosomal dominant polycystic kidney disease. Nephron 1991; 57: 40.
17. Rischen-Vos J, van der Woude FJ, Tegzess AM, et al. Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with non-diabetic patients. Nephrol Dial Transplant 1992; 7: 433.
18. Hoitsma AJ, van Lier HJJ, Reekers P, Koene RAP. Improved patient and graft survival after treatment of acute rejections of cadaveric renal allografts with rabbit antithymocyte globulin. Transplantation 1985; 39: 274.
19. Gilks WR, Gore SM, Bradley BA. Analyzing transplant survival data. Transplantation 1986; 42: 46.
20. Pechan W, Novick AC, Braun WE, Nakomoto S, Popowniak K, Steinmuller D. Management of end stage polycystic kidney disease with renal transplantation. J Urol 1981; 125: 622.
21. Sanfilippo FP, Vaughn WK, Peters TG, Bollinger RR, Spees EK. Transplantation for polycystic kidney disease. Transplantation 1983; 36: 54.
22. Ho-Hsieh H, Novick AC, Steinmuller D, Streem SB, Buszta C, Goormastic M. Renal transplantation for end-stage polycystic kidney disease. Urology 1987; 30: 322.
23. Mendelssohn DC, Harding ME, Cardella CJ, Cook GT, Uldall PR. Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation. Clin Nephrol 1988; 30: 315.
24. Matas AJ, Brayman KL, Gillingham KJ. Presentation of renal transplant graft survival data-where should “death with a functioning graft” be included? Clin Transplant 1990; 4: 142.
25. Feutren G, Mihatsch MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654.
26. Almond PS, Gillingham K, Sibley R, Manivel C, Najarian JS, Matas AJ. The impact of cyclosporine and cyclosporine nephrotoxicity on long-term renal allograft function. Dialysis Transplant 1992; 21: 682.
27. Amamoo DG, Woods JE, Anderson CF. Renal transplantation in end stage polycystic renal disease. J Urol 1974; 112: 443.
28. Jakobsen A, Birkeland SA, Gabel H, et al. Renal transplantation in polycystic renal disease-a joint Scandinavian report. Scand J Urol Nephrol [Suppl] 1980; (suppl 54): 71.
29. Schom TF, Kliem V, Bojanovski M, et al. Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients. Transplant Int 1991; 4: 92.
30. Kasiske BL, Umen AJ. Persistent hyperlipidemia in renal transplant patients. Medicine 1987; 66: 309.
31. Versluis DJ, Wenting GJ, Derkx FHM, Schalekamp MADH, Jeekel J, Weimar W. Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why. Transplantation 1987; 44: 387.
32. Hricik DE, Mayes JT, Schulak JA. Independent effects of cyclo sporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis 1991; 18: 353.
33. Kasiske BL, Tortorice KL, Heim-Duthoy KL, Awni WM, Ven- kateswara Rao K. The adverse impact of cyclosporine on serum lipids in renal transplant patients. Am J Kidney Dis 1991; 17: 700.
34. Fischel RJ, Payne WD, Gillingham KJ, et al. Long-term outlook for renal transplant recipients with one-year function. Transplantation 1991; 51: 118.
35. Hill MN, Grossman RA, Feldman HI, Hurwitz S, Dafoe DC. Changes in causes of death after renal transplantation, 1966 to 1987. Am J Kidney Dis 1991; 17: 512.
36. Delaney V, Sumrani N, Butt KMH, Hong JH. The impact of cyclosporin in patients with adult polycystic kidney disease following transplantation. Nephron 1991; 59: 537.
37. Balch CM, Morgan JM, Sterling WA, Bradley EL, Diethelm AG. Kidney transplantation in patients with end stage congenital renal disease. Am J Surg 1975; 130: 303.
38. Gilks WR, Bradley BA, Gore SM, Selwood NH. Immunogenetic and clinical factors affecting renal transplantation. Transplantation 1986; 42: 39.
39. Yarimizu SH, Susan LP, Straffon RA, Stewart BH, Magnusson MO, Nakamoto SS. Mortality and morbidity in pretransplant bilateral nephrectomy: analysis of 305 cases. Urology 1978; 12: 55.
40. Calman KC, Bell PRF, Briggs JD, Hamilton DNH, MacPherson SG, Patón AM. Bilateral nephrectomy prior to renal transplantation. Br J Surg 1976; 63: 512.
41. Rayner BL, Cassidy MJD, Jacobsen JE, Pascoe MD, Pontin AR, Van Zyl Smit R. Is preliminary binephrectomy necessary in patients with autosomal dominant polycystic kidney disease undergoing renal transplantation? Clin Nephrol 1990; 34: 122.
42. Bennett AH, Stewart W, Lazarus JM. Bilateral nephrectomy in patients with polycystic renal disease. Surg Gynecol Obstet 1973; 137: 819.
43. Sheinfeld J, Linke CL, Talley TE, Linke CA. Selective pre-trans plant nephrectomy: indications and perioperative management. J Urol 1985; 133: 379.
44. The 13th report of the human renal transplant registry. Transplant Proc 1977; 9: 9.
45. Williams G, Mitcheson HD, Castro JE. Transplantation for polycystic kidney disease. Urology 1978; 12: 628.
46. Pearson JC, Amend W Jr, Vincenti FG, Feduska NJ, Salvatierra O Jr. Post-transplantation pyelonephritis: factors producing low patient and transplant morbidity. J Urol 1980; 123: 153.
47. Williams LC, Turney JH, Bewick M, et al. Risks and benefits of bilateral nephrectomy: an analysis of 134 cases. Proc EDTA 1980; 17: 507.